menu search

SONN / Why Is Sonnet BioTherapeutics (SONN) Stock Down 5% Today?

Why Is Sonnet BioTherapeutics (SONN) Stock Down 5% Today?
Sonnet BioTherapeutics (NASDAQ: SONN ) stock is taking a beating on Monday after the company announced a public stock offering. Investors will note that this public stock offering comes from selling stockholders and not directly from Sonnet BioTherapeutics. Read More
Posted: Jul 31 2023, 09:23
Author Name: InvestorPlace
Views: 102819

SONN News  

Why Is Sonnet BioTherapeutics (SONN) Stock Down 33% Today?

By InvestorPlace
October 25, 2023

Why Is Sonnet BioTherapeutics (SONN) Stock Down 33% Today?

Sonnet BioTherapeutics (NASDAQ: SONN ) stock is falling on Wednesday after the biotechnology company revealed details of a public share offering. Tha more_horizontal

Why Is Sonnet BioTherapeutics (SONN) Stock Down 5% Today?

By InvestorPlace
July 31, 2023

Why Is Sonnet BioTherapeutics (SONN) Stock Down 5% Today?

Sonnet BioTherapeutics (NASDAQ: SONN ) stock is taking a beating on Monday after the company announced a public stock offering. Investors will note t more_horizontal

3 Hot Penny Stocks To Watch Under $1, Time To Buy?

By PennyStocks
May 18, 2023

3 Hot Penny Stocks To Watch Under $1, Time To Buy?

Penny stocks under $1 to watch this week. The post 3 Hot Penny Stocks To Watch Under $1, Time To Buy? more_horizontal

Trending Penny Stocks to Buy This Month? 3 to Watch in April

By PennyStocks
April 17, 2022

Trending Penny Stocks to Buy This Month? 3 to Watch in April

Can these penny stocks continue to climb this month? The post Trending Penny Stocks to Buy This Month? more_horizontal

Sonnet Shares Surge As FDA Clears Its First Human Trial For Solid Tumor Candidate

By Benzinga
March 16, 2022

Sonnet Shares Surge As FDA Clears Its First Human Trial For Solid Tumor Candidate

The FDA has signed off Sonnet BioTherapeutics Holdings Inc's (NASDAQ: SONN) Investigational New Drug (IND) application for SON-1010, a proprietary more_horizontal

Sonnet BioTherapeutics (SONN) Stock: Why The Price Fell

By Pulse2
February 9, 2022

Sonnet BioTherapeutics (SONN) Stock: Why The Price Fell

The stock price of Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) fell by 4.57% in the most recent trading session. This is why it happened. more_horizontal

Sonnet BioTherapeutics (SONN) Stock: Why The Price Fell

By Pulse2
February 9, 2022

Sonnet BioTherapeutics (SONN) Stock: Why The Price Fell

The stock price of Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) fell by 4.57% in the most recent trading session. This is why it happened. more_horizontal

Sonnet BioTherapeutics (SONN) Stock: Why The Price Fell

By Pulse2
February 9, 2022

Sonnet BioTherapeutics (SONN) Stock: Why The Price Fell

The stock price of Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) fell by 4.57% in the most recent trading session. This is why it happened. more_horizontal


Search within

Pages Search Results: